文献速递痛风与晶体性关节病

美国痛风与高尿酸血症的患病率及趋势

Gout and hyperuricaemia in the USA: prevalence and trends.
PubMed 文献 · Rheumatology (Oxford) · 2019-01-01

该研究基于2007-08至2015-16年美国国家健康与营养调查(NHANES)≥20岁成人数据,分析痛风与高尿酸血症患病率。

要点

  • 2007-08至2015-16年龄标化患病率无显著变化。

研究设计与样本

  • 研究分析了2007-08至2015-16年美国国家健康与营养调查(NHANES)中≥20岁成人数据。
  • 痛风依据家庭访谈问题「医生或其他健康专业人员是否曾告知您患有痛风?」识别。
  • 高尿酸血症定义为血清尿酸水平>0.40 mmol/l(6.8 mg/dl)。

主要发现

  • 痛风和高尿酸血症的年龄标化患病率未发现显著趋势。
  • 2007-08与2015-16年龄标化率之间的统计比较不显著。

临床怎么用

  • 美国成人痛风和高尿酸血症年龄标化患病率近十年保持稳定,但痛风绝对患病人数增加,提示临床负担持续存在。

局限性

  • 痛风基于自报医生诊断,未经过病历核实。
  • 高尿酸血症仅基于单次血清尿酸测量定义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Several recent observations have suggested that the prevalence of gout may be increasing worldwide, but there are no recent data from the USA. We analysed the prevalence of hyperuricaemia and gout in the US population from 2007-08 to 2015-16. METHODS: We studied adults ⩾20 years of age from the National Health and Nutrition Examination Survey from 2007-08 to 2015-16. Persons with gout were identified from the home interview question 'Has a doctor or other health professional ever told you that you had gout?' Hyperuricaemia was defined as a serum urate level >0.40 mmol/l (6.8 mg/dl) (supersaturation levels at physiological temperatures and pH). RESULTS: In 2015-16, the overall prevalence of gout among US adults was 3.9%, corresponding to a total affected population of 9.2 million. Hyperuricaemia (>0.40 mmol/l or 6.8 mg/dl) was seen in 14.6% of the US population (estimated 32.5 million individuals). No significant trends were identified in the age-adjusted prevalence of gout and hyperuricaemia. Statistical comparisons between 2007-08 and 2015-16 age-adjusted rates were not significant. CONCLUSION: While the age-adjusted prevalence of gout and hyperuricaemia has remained unchanged in the most recent decade from 2007-08 to 2015-16, the estimated total number of persons with self-reported gout has increased from 8.3 million to 9.2 million. The age-adjusted prevalence of hyperuricaemia has declined slightly, but the total number of affected individuals is virtually identical (32.5 million in 2015-16 compared with 32.1 million in 2007-08).

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Singh G, Lingala B, Mithal A, et al. Gout and hyperuricaemia in the USA: prevalence and trends. Rheumatology (Oxford). 2019. PMID: 31168609. doi:10.1093/rheumatology/kez196

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。